Free tool
FDA Clearance Tracker
Last checked: Nov 19, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code NOY: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia. Open this device type's page
4 decisions
product code NOY. Showing 1 to 4, newest first. PMA results are original approvals and panel-track supplements.
Biocompatibles UK Ltd (Part of Boston Scientific Corporation
K203276 · Decided Apr 20, 2021 · 165 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
- HydroPearl Microspheres510(k)
K192684 · Decided Jan 22, 2020 · 118 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
K180102 · Decided Apr 19, 2018 · 93 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.